Journal article

Current and emerging pharmacotherapy for emergency management of preeclampsia.

Annie G Cox, Sarah A Marshall, Kirsten R Palmer, Euan M Wallace

Expert Opin Pharmacother | Published : 2019


INTRODUCTION: Preeclampsia is a disease specific to pregnancy characterised by new onset hypertension with maternal organ dysfunction and/or fetal growth restriction. It remains a major cause of maternal and perinatal morbidity and mortality. For fifty years, antihypertensives have been the mainstay of treating preeclampsia, reducing maternal morbidity and mortality. With increased knowledge of the mechanisms underlying the disease has come opportunities for novel therapies that complement antihypertensives by protecting the maternal vasculature. Areas covered: In this review, the authors consider, in detail, the antihypertensives commonly used today in the emergency care of women with sever..

View full abstract